Multiple Endocrine Neoplasia Type 2

National Organization for Rare Disorders, Inc.

Skip to the navigation

Important
It is possible that the main title of the report Multiple Endocrine Neoplasia Type 2 is not the name you expected.

Disorder Subdivisions

  • None

General Discussion

Multiple endocrine neoplasia (MEN) type 2 is a rare genetic disorder characterized by an increased risk of developing a specific form of thyroid cancer (medullary thyroid carcinoma) and benign tumors affecting additional glands of the endocrine system. The endocrine system is the network of glands that secrete hormones into the bloodstream where they travel to various areas of the body. These hormones regulate the chemical processes (metabolism) that influence the function of various organs and activities within the body. Hormones are involved in numerous vital processes including regulating heart rate, body temperature and blood pressure. Glands affected in MEN type 2 may secrete excessive amounts of hormones into the bloodstream, which can result in a variety of symptoms.

MEN type 2 is divided into three subtypes: MEN type 2A, MEN type 2B, and familial medullary thyroid carcinoma (FMTC). Medullary thyroid carcinoma (MTC) affects nearly all individuals with MEN type 2 regardless of the subtype. Additional symptoms may occur depending upon the specific subtype present. In FMTC, no other symptoms besides the carcinoma are present. MEN type 2 can run in families or can occur as the result of a spontaneous genetic change (i.e., new mutation) that occurs randomly for no apparent reason.

Supporting Organizations

American Cancer Society, Inc.

250 Williams NW St
Ste 6000
Atlanta, GA 30303
USA
Tel: (404)320-3333
Tel: (800)227-2345
Website: http://www.cancer.org

American Multiple Endocrine Neoplasia Support

1027 Hampshire Drive
Maryville, TN 37801
Tel: (865)238-5872
Fax: (865)238-5844
Tel: (866)612-8579
Email: Linda@hagemanfoundation.org
Website: http://www.amensupport.org

Association for Multiple Endocrine Neoplasia Disorders (AMEND)

The Warehouse
No. 1 Draper Street
Kent, TN4 0PG
United Kingdom
Tel: 441892516076
Fax: 441892516076
Email: jo.grey@amend.org.uk
Website: http://www.amend.org.uk

Hormone Health Network Endocrine Society

2055 L Street NW
Suite 600
Washington, DC 20036
Tel: (202)971-3636
Fax: (202)736-9705
Tel: (888)363-6274
Email: hormone@endocrine.org
Website: http://www.hormone.org/

NET Patient Foundation

Boxtrees Farm
The Farm House
Hockley Heath, B94 6EA
United Kingdom
Tel: 8004346476
Website: http://www.netpatientfoundation.org

NIH/National Institute of Diabetes, Digestive & Kidney Diseases

Office of Communications & Public Liaison
Bldg 31, Rm 9A06
Bethesda, MD 20892-2560
Tel: (301)496-3583
Email: NDDIC@info.niddk.nih.gov
Website: http://www2.niddk.nih.gov/

Pheo Para Troopers

P.O. Box 2064
Kokomo, IN 46904
Email: info@pheoparatroopers.org
Website: http://www.pheoparatroopers.org

ThyCa: Thyroid Cancer Survivors' Association, Inc.

PO Box 1545
New York, NY 10159-1545
Fax: (630)604-6078
Tel: (877)588-7904
Email: thyca@thyca.org
Website: http://www.thyca.org

For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders (NORD). For a full-text version of this report, go to www.rarediseases.org and click on Rare Disease Database under "Rare Disease Information".

The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only.

It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report.

This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.

Last Updated:  1/28/2014
Copyright  2014 National Organization for Rare Disorders, Inc.